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Protein stability aspects
Conformational stability
Colloidal stability
Interfacial stability
Chemical stability
Protein aggregation due to poor physical stability
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How to select formulations where protein aggregation is 
suppressed during storage?
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Our aim is to test and 
improve the predictions from 
stability-indicating methods
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6Differential scanning microcalorimetry can be used to determine the 
(apparent) protein melting temperature Tm in different formulations
Basic assumption of this approach: 
The long-term stability of the formulations
correlates with the (apparent) protein 
melting temperatures
Melting of GCSF in 
different formulations
Tm
7Correlation between prediction from melting temperature of GCSF and 
storage stability at 4 ⁰C (Youssef and Winter 2013)
Other examples showing that DSC can provide only some predictions for storage stability:
Best 50 % prediction
Storage stability ranking
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8However, this approach had the following limitations:
► Low-throughput: only one sample per run possible (ca. 3 samples per day)
► Sample heating: some excipients change properties with temperature
► Large sample volume: 550 µl measurement volume -> 800 µl handling volume
► Limited prediction reliability: “Tm showed a limitation in predicting the exact ranking”
Measuring Tm with differential scanning calorimetry (DSC) offers:
► Some predictions which formulations are stable during storage
The Tm approach with DSC in brief
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Nano „Differential 
Scanning Fluorimetry“
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nanoDSF measures protein unfolding by detecting changes in the 
intrinsic protein fluorescence
nanoDSF provides melting temperatures like other methods faster and with less sample
µDSC near-UV CD nanoDSF
≈ 550 µL ≈ 600 µL ≈ 10 µL
≈ 3 samples/day ≈ 6 samples/1.5 h ≈ 48 samples/1.5 h
Extensive 
hands-on time
Medium 
hands-on time
Very short 
hands-on time
nanoDSF: Thermal unfolding of 
interferon α2a at different pH
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nanoDSF: Thermal unfolding of 
interferon α2a as a function of [NaCl]
The data on these graphs is 
generated in 90 minutes 
with 150 µL of sample
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However, this approach has the following limitations:
► Sample heating: some excipients change properties with temperature
► Limited prediction reliability: Tm shows a limitation in predicting the exact ranking
Measuring Tm with nanoDSF offers:
► Some predictions which formulations are stable during storage
► High-throughput: typically 48 samples in 1.5 hours
► Small sample volume: 10 µL for one measurement
The Tm approach with nanoDSF in brief
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Thermal denaturation techniques like DSC and nanoDSF work by increasing 
sample temperature to measure melting temperatures
➢ High demand for orthogonal isothermal techniques 
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Isothermal 
Chemical 
Denaturation
Freire et al. (2013) Drug discovery today, 18(19-20), pp. 1007-1013.
Pace (1986) In Methods in enzymology (Vol. 131, pp. 266-280). Academic Press.
Isothermal Chemical Denaturation (ICD) for protein formulation
Increasing concentrations of a chemical denaturant are used to cause protein unfolding
folded
unfolded
partially 
unfolded mG = slope
Cm
dG = mG * Cm
The ICD data can provide the following protein stability-indicating parameters:
Cm– the “melting” concentration of denaturant needed to unfold 50 % of the protein;
mG – the “m-value” is an indicator for the cooperativity of the unfolding;
dG – the Gibbs free energy of protein unfolding;
dG (kcal/mol) % Unfolded protein
0 50
2.7 1
4.1 0.1
5.5 0.01
6.8 0.001
8.2 0.0001
9.6 0.00001
The true dG allows to calculate the 
fraction of unfolded protein species
dG is a measure of the protein 
conformational stability at a given 
temperature.
dG = -RTln(Keq)
Unfolded Folded
Keq
dG4 ⁰C dG40 ⁰C
Determining the true dG is possible only when the unfolding of the 
protein in the denaturant is fully reversible
The concentration dependence of the apparent dG
can indicate whether a protein is likely to aggregate 
from its native or unfolded state
Schön et al. (2015) Analytical biochemistry, 488, pp. 45-50.; Clarkson et al. (2016) Drug discovery today, 21(2), pp. 342-347.;
dGapp = dG° + RTln(1 + jKj[N]
j-1)
dGapp = dG° - RTln(1 + jKj[D]
j-1)
dG = -RTln(Keq)
Concentration dependence of the Gibbs 
free energy (dG) of protein unfolding
Protein aggregation at 40 ⁰C
Svilenov, H., Markoja, U. and Winter, G., 2018.. Eur J Pharm Biopharm, 125, pp.106-113.
This approach is useful and provides orthogonal information during the selection of 
stable protein formulations
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However, this approach had the following limitations:
► Medium throughput: Depends on the experimental set-up 
► Medium to high sample volume: Depends on the experimental set-up 
► Limited prediction accuracy: The exact order of the formulations is still not known
Measuring dG and the concentration dependence of dG with ICD offers:
► Some predictions which formulations are stable during storage
► No sample heating
The dG and dGtrend approach with ICD in brief
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Isothermal 
Refolding Assay 
to Assess Protein 
Aggregation
Basic assumption of this approach: 
The aggregation of the partially unfolded protein during refolding
correlates with the long-term storage stability
Svilenov, H. and Winter, G., 2019.. Eur J Pharm Biopharm, 137, pp. 131-139 
SEC-MALS chromatograms of 
native and refolded mAb-A
Effect of formulation on the relative monomer 
yield of mAb-A after refolding from urea
Protein aggregation during dialysis refolding depends on the formulation
Svilenov, H. and Winter, G., 2019.. Eur J Pharm Biopharm, 137, pp. 131-139 
Can this approach rank the storage stability of the formulations?
The relative monomer yield from the ReFOLD assay correlates well with the amount of 
protein aggregates detected after long-term storage for 12 months at 4 ⁰C
Formulations of mAb-A Formulations of mAb-B
after 12 months at 4 ⁰C after 12 months at 4 ⁰C
Svilenov, H. and Winter, G., 2019.. Eur J Pharm Biopharm, 137, pp. 131-139 
The relative monomer yield from the ReFOLD assay correlates well with the 
number of subvisible particles detected after storage for 12 months at 25 ⁰C
Svilenov, H.  et al. In preparation
mAb-C
The ReFOLD assay offers:
► Good predictions which formulations are stable during storage
► No sample heating
► Medium to high throughput: 96 well plate, <48 hours to complete
► Small to medium sample volume: between 10 and 100 µL 
The approach with the ReFOLD assay in brief
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Which stability-indicating method to choose?
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≥ 50 formulations
≥ 20 formulations
≈ 5 formulations
≈ 1-2 
formulations
Thermal 
denaturation
Isothermal 
characterization
Accelerated stability 
studies 
Long-term stability 
studies
nanoDSF (DSC as backup)
Low volume, Fast, Useful, Limitations
ReFOLD (also ICD, DLS, SLS)
Low volume, Better predictions
Storage at 25 ⁰C
Storage at 4 ⁰C
New therapeutic protein candidate
Protein solution with optimized
physical stability
How different methods can be combined in formulation development
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In summary:
➢ Use a combination of stability-indicating methods
➢ Know the strengths and limitations of each method
➢ Validate novel predictive methods with long-term stability data
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